Prosecution Insights
Last updated: May 29, 2026

Examiner: MINCHELLA, KAITLYN L

Tech Center 1600 • Art Units: 1631 1672 1685

This examiner grants 27% of resolved cases

Performance Statistics

27.1%
Allow Rate
-32.9% vs TC avg
206
Total Applications
+21.7%
Interview Lift
1582
Avg Prosecution Days
Based on 155 resolved cases, 2023–2026

Rejection Statute Breakdown

19.3%
§101 Eligibility
4.7%
§102 Novelty
46.8%
§103 Obviousness
7.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19341734 PLATFORMS, SYSTEMS, AND METHODS FOR PATHWAY OPTIMIZATION FOR PROCESS BOTTLENECKS IN SYNTHETIC BIOLOGY DEVELOPMENT Non-Final OA X Development LLC
17629327 DETECTING NEURALLY PROGRAMMED TUMORS USING EXPRESSION DATA Final Rejection Genentech, Inc.
17186816 METHOD FOR VERIFYING CULTIVATION DEVICE PERFORMANCE Final Rejection Hoffmann-La Roche Inc.
17735117 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL Final Rejection Tempus AI, Inc.
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA Final Rejection TEMPUS AI, INC.
16732229 TRANSCRIPTOME DECONVOLUTION OF METASTATIC TISSUE SAMPLES Final Rejection TEMPUS AI, INC.
17204892 CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER Non-Final OA The Johns Hopkins University
17188737 PEAK-PRESERVING AND ENHANCING BASELINE CORRECTION METHODS FOR RAMAN SPECTROSCOPY Final Rejection Virginia Tech Intellectual Properties, Inc.
17502661 METHOD AND APPARATUS FOR PROVIDING INFORMATION ASSOCIATED WITH IMMUNE PHENOTYPES FOR PATHOLOGY SLIDE IMAGE Final Rejection LUNIT Inc.
17725354 Genome Feature Extraction Method, Disease Prediction Method, Apparatus and Device Non-Final OA Alibaba (China) Co., Ltd.
17766006 BIOCOMPATIBLE NUCLEIC ACIDS FOR DIGITAL DATA STORAGE Non-Final OA SORBONNE UNIVERSITE
16794696 ALIGNMENT USING HOMOPOLYMER-COLLAPSED SEQUENCING READS Final Rejection Pacific Biosciences of California, Inc.
17838115 METHOD AND SYSTEM FOR IMPROVED MANAGEMENT OF GENETIC DISEASES Non-Final OA Alexion Pharmaceuticals, Inc.
18369788 SYSTEMS AND METHODS FOR ENGINEERING PROTEIN ACTIVITY Final Rejection Aether Biomachines, Inc.
15489658 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES Final Rejection UNIVERSITY OF MARYLAND, BALTIMORE
15028253 METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES Final Rejection UNIVERSITY OF MARYLAND, Baltimore
18118024 FRAGMENTATION FOR MEASURING METHYLATION AND DISEASE Final Rejection Centre for Novostics Limited
16721619 CELL-FREE DNA END CHARACTERISTICS Non-Final OA GRAIL, Inc.
17860782 SOIL HEALTH INDICATORS USING MICROBIAL FUNCTIONAL GENES Final Rejection MIRATERRA INC.
17184505 SYSTEMS AND METHODS FOR SEQUENCE DESIGN Final Rejection Baidu USA, LLC
17709614 SYSTEMS AND METHODS FOR GENERATING REPRODUCED ORDER- DEPENDENT REPRESENTATIONS OF A CHEMICAL COMPOUND Final Rejection Collaborative Drug Discovery, Inc.
17587195 WEB-BASED PHARMACOGENOMICS TOOL Final Rejection DASMAN DIABETES INSTITUTE
17556068 METHODS AND SYSTEMS FOR IDENTIFYING TARGET GENES Final Rejection Algen Biotechnologies, Inc.
17613966 SIMULATION OF TEMPERATURES IN THE BODY Final Rejection ELMEDIX NV
17370759 IDENTIFYING TRANSITION POINTS IN CHEMICAL REACTIONS Non-Final OA AZURE VAULT LTD.
16945644 SYSTEMS AND METHODS OF USING MACHINE LEARNING ANALYSIS TO STRATIFY RISK OF SPONTANEOUS PRETERM BIRTH Final Rejection NX Prenatal Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month